FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MORDELET, E.
Right arrow Articles by GRANON, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MORDELET, E.
Right arrow Articles by GRANON, S.
(The FASEB Journal. 2004;18:1851-1861.)
© 2004 FASEB

Histopathological and cognitive defects induced by Nef in the brain

ELODIE MORDELET1, KARIMA KISSA*, ARNAUD CRESSANT{dagger}, FRANCOISE GRAY{ddagger}, SIMONA OZDEN§, CATHERINE VIDAL||, PIERRE CHARNEAU** and SYLVIE GRANON{dagger}{dagger}

Unité Postulante "Mycologie Moléculaire," Institut Pasteur, Paris, France;
* Unité Postulante "Macrophages et Développement de l’Immunité," Institut Pasteur, Paris, France,
{dagger} Unité "Rétrovirus & Transfert génétique," Institut Pasteur, Paris, France;
{ddagger} Service d’Anatomie et de Cytologie Pathologiques, Hôpital Lariboisiere, Paris, France;
§ Unité "Epidémiologie & Physiopathologie des Virus Oncogènes," Institut Pasteur, Paris, France;
|| CEA, Service de Neurologie, CRSSA, EPHE, Fontenay-aux-Roses, France;
** Groupe "Virologie Moléculaire & Vectorologie," Institut Pasteur, Paris, France; and
{dagger}{dagger} Unité "Récepteurs & Cognition," Institut Pasteur, Paris, France

1 Correspondence: Institut Pasteur, 25 rue du Dr. Roux, 75015 Paris, France. E-mail:mordelet{at}pasteur.fr; or granon{at}pasteur.fr


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Complex mechanisms of human immunodeficiency virus type-1 (HIV-1) brain pathogenesis suggest the contribution of individual HIV-1 gene products. Among them, the Nef protein has been reported to harbor a major determinant of pathogenicity in AIDS-like disease. The goal of the present study was to determine whether Nef protein expressed in vivo by primary macrophages could induce a brain toxicity also affecting the behavior of the rat. To achieve this goal we grafted Nef-transduced macrophages into the rat hippocampus. Two months post-transplantation, we observed that Nef induces monocyte/macrophage recruitment, expression of TNF-{alpha}, and astrogliosis. No apoptotic event was detected. We further demonstrated that Nef neurotoxicity is associated with cognitive deficits.—Mordelet, E., Kissa, K., Cressant, A., Gray, F., Ozden, S., Vidal, C., Charneau, P., Granon, S. Histopathological and cognitive defects induced by Nef in the brain.


Key Words: neuropathology • behavior • bone marrow-derived macrophages


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
SOON AFTER EXPOSURE, the human immunodeficiency virus type 1 (HIV-1) invades the central nervous system (CNS) and induces AIDS cognitive disorders (1 2 3 4 5 6) . The neuropathological damages commonly known as AIDS cognitive disorders (ADC) are characterized by progressive deterioration of mental and motor functions. When observed, brain lesions mainly affect the white matter, the basal ganglia, the cerebral cortex, and the hippocampus (1 , 7 8 9) . However, a non-negligible percentage of patients show no lesion but exhibit minor cognitive deficits that may constitute a pathology different from ADC (10) . At a cellular level, the main reservoir for HIV replication are monocyte-derived macrophages/microglial cells (11 12 13) . A low level of infected astrocytes, neurons, and brain capillary endothelial cells has been reported in brain specimens with ADC (14 15 16 17 18) .

Several lines of recent in vitro and in vivo evidence suggest that different factors are involved in HIV-1 neuropathogenesis. Among them, viral products (Tat, gp120, gp160, Nef), cellular products (acid quinolinic, NO, etc.), cytokine induction (TNF-{alpha}, IL-8, INF-{gamma}), and excitotoxic injuries may lead to neurodegeneration or neuronal loss (19 20 21 22 23) .

Nef protein is precociously and strongly expressed during HIV-1 infection (24 , 25) . Immunohistochemical staining has revealed an overexpression of Nef compared with other viral proteins in HIV-infected astrocytes and brain biopsies (26 , 27) . In SIV-infected monkeys, it has been shown that Nef expression is essential to maintain a high replication level of the virus and promote the development of AIDS (28) . In a transgenic mouse model, Skowronski and collaborators (29) showed that the expression of Nef in lymphocytes TCD4+ induced modifications in the signaling pathway of those cells leading to their progressive death. Moreover, among the transgenic mice expressing the complete coding sequences of HIV-1 in T CD4+ cells, only the Nef transgenic mice developed a severe AIDS-like disease, detected in all organs, including the brain (30) . Altogether, these data suggest a potentially important and specific role for Nef in cellular dysfunctions and its contribution to the development of the neuropathology associated with AIDS (31 32 33 34) .

A highly significant increase in the number of macrophages in patients who suffered from ADC has been reported in postmortem studies, pointing to a possible role of macrophage infiltrates for the exacerbation of neuronal dysfunction (35) . Several clinical and experimental studies have focused on the production of chemotactic factors during HIV infection (36 37 38 39) . Recently, Koedel and collaborators (40) have proposed that Nef is essential for AIDS neuropathology as a mediator for the recruitment of leukocytes. Therefore, the presence of leukocytes within the brain may serve as a vehicle for the virus and may perpetrate the disease through their production of neurotoxins. Overall, this corpus of results led us to investigate the role of the Nef protein when expressed by some preferential HIV target cells (macrophages). In parallel, we performed direct injection of vector particles known to target mainly astrocytes in order to see whether the expression of Nef in the astrocytes would be different from its expression in macrophages.

The main aim of our research was to determine in vivo whether Nef, expressed by macrophages when transplanted onto the rat brain could induce observable early toxicity. To address this, we had efficiently transduced ex vivo rat primary macrophages with a lentiviral vector (41) and showed that, in vivo, transplants of transduced macrophages into the rat brain maintain long-term expression of a control protein (green fluorescent protein, or GFP) for up to 90 days without any significant sign of astrogliosis.

In the present study, we showed a sustained, stable, and noncytotoxic expression of Nef in bone marrow-derived macrophages (BMDM) in culture. This first step allowed us to graft primary macrophages expressing Nef onto the rat hippocampus and study their effects on behavior and histopathology. Our present results corroborate the presence of Nef in the hippocampus with its histopathological effects including monocyte/macrophage recruitment, expression of the proinflammatory cytokine TNF-{alpha}, and astrogliosis. We found no correlation between the presence of Nef in the brain and certain apoptotic events. We show that Nef neurotoxicity is associated with cognitive deficits specific to hippocampal dysfunction.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Primary culture of BMDM
Bone marrow cells were collected from femurs and tibias of adult male Long-Evans rats (Janvier, Le Genest-St.-Isle, France) as described (41 , 42) . Briefly, cells were flushed out with a 25 gauge needle into ice-cold phosphate-buffered saline (PBS) without Mg2+, Ca2+. The marrow plugs were centrifuged (1500 g, 10 min, 4°C). After dissociation and elimination of the red cells, bone marrow cells were seeded onto 6-well dishes (4x106 cells/mL, Costar, Cambridge, MA, USA) in RPMI 1640 (Seromed, Berlin, Germany) supplemented with 2 mM L-glutamine, 2 0 mM NaHCO3, 5U/mL penicillin, 50 µg/mL streptomycin, and 10% heat-inactivated fetal calf serum. The conditioned medium from L929 (5%) as a source of colony-stimulating factor 1 (CSF-1) was added in RPMI supplemented (43) . At day 3, adherent and differentiated BMDM were then used for transduction. For immunofluorescence studies, glass coverslips were placed into the wells of cultures plates. For in vivo transplantation, the cells were detached with trypsin-EDTA 1x, washed and resuspended in serum and CSF-1 free medium at 2.5 x 107 cells/mL.

Lentiviral vector
A three-plasmid expression system was used to generate vector particles by transient transfection of 293T cells using the calcium phosphate coprecipitation technique as described (44 , 45) . We used the vector plasmid encoding an hCMV-driven expression cassette of the GFP or Nef cDNA (TRIP vector). The encapsidation plasmid (p8.2) provides all vector proteins and the VSV-G envelope expression plasmid (phCMV-G) permits the production of vector particles. The system was improved by the deletion of the U3 region of the 3' long terminal repeat (LTR) of the DNA used to produce the TRIP vector (46) . The vector stocks were treated with DnaseI as described (45) . Vector titration was assayed for p24 Gag antigen by ELISA assay (NEN Life Science Products, Boston, MA, USA). In vitro transduction experiments were done in 6-well plates. BMDM were transduced using 150 ng of p24 TRIP-GFP or 300 ng of p24 TRIP-Nef vector particles, respectively/106 cells.

Intracerebral injections of viral particles were performed using 1.5 µL of TRIP-GFP (100 ng/µL p24) and 4.3 µL of TRIP-Nef vector particles (70 ng/µL p24).

Quantitation of gene transfer efficiency
Transduction efficiency was evaluated using flow cytometry. The mononuclear phagocyte population (BMDM) was selected by granularity and cell size as described (41) . After suitable gating, 10,000 events were collected for each experiment in FL1-height (488 wavelength) (CellQuest software; Becton Dickinson, Pont de Claix, France). M1 represents the mean of the signal corresponding to the negative-untransduced macrophage population and M2 the percentage of Nef- or GFP-transduced macrophages.

Immunoprecipitation and immunoblot analysis
Primary macrophages were transduced ex vivo for 48 h. Cell extracts were precipitated in lysis buffer, loaded, denaturated, and frozen. Supernatants were collected, concentrated (Centriplus, Amicon, Millipore, Yvelines, France), and treated as described above. Protein concentration was determined using BCA reagent kit (Pierce, Rockford, IL, USA). For each sample, proteins (50 µg) were fractionated on 16% SDS-PAGE gradient gels under nonreducing conditions and transferred to a cellulose membrane. Nef was labeled using Nef antibody (Hybridolab, Pasteur), followed by a secondary anti-mouse horseradish peroxidase. Proteins were detected with the chemiluminescence detection Kit (Amersham, Biosciences UK Limited, Little Chalfont, England, UK).

Intracerebral macrophage transplantation
Autologous engraftments were performed using BMDM transplanted into the brain of Long Evans rats (n=24). Male adult rats (250–300 g) were anesthetized with sodium pentobarbital (50 mg/kg; Sanofi, France) and positioned onto a stereotaxic frame as described (41) . Holes were drilled into the appropriate locations and a 10 µL Hamilton syringe was used to inject the cellular suspension or the vector particles into the hippocampus (AP–2.6 and –4.2, L±1.4 and ±3, DV–3.3 and –3.5) at a slow time course (0.2 µL/min). At cessation of the injection, the needle was left in place for 15 min before withdrawal. Four different groups of animals were grafted bilaterally: 1) six rats with Nef-transduced macrophages and, as a control, six rats with GFP-transduced BMDM, 2) six rats injected with TRIP-Nef vector particles; as a control, six rats injected with TRIP-GFP vector particles. One animal injected with TRIP-Nef vector particles died during surgery. Animals were killed 2 months after cell transplantation or vector particle injection. Rats were perfused intracardially with 4% paraformaldehyde (PFA). Brains were removed, dipped in 20% sucrose solution, frozen in Tissue-tek OCT (Miles, Elkhart, IN, USA), and stored at –80°C.

Immunocytochemical procedures
In vitro, BMDM cells were washed, fixed with 4% PFA solution for 20 min at room temperature and rinsed with PBS. Cells were then treated with a blocking solution (10% goat serum and 0.2% Triton X-100 in PBS) and incubated with Nef antibody (Hybridolab, Pasteur). Next, the secondary antibody FITC-conjugated goat anti-mouse IgG (Beckman Coulter, Roissy, France) diluted 1:500 in PBS was added to the cells. The glass coverslips were mounted in fluosaved reagent (Calbiochem, Meudon, France) and stored at –20°C. The GFP-autofluorescent and FITC labelings were analyzed by optical microscope (Zeiss, le Pecq, France).

For in situ immunohistochemistry, coronal OCT-coated slices (cryostat, 25 µm) were rehydrated in PBS and incubated in 0.3% hydrogen peroxide in methanol for 20 min at room temperature in a moist chamber to inhibit endogenous peroxidase. Slices were then treated with a blocking solution containing 10% goat serum and 0.2% Triton X-100 in PBS. To characterize the macrophages, cells were incubated with mouse IgG anti-rat Mac-1 (Serotec, Oxford, UK, diluted 1:100 in blocking solution) (47 , 48) . Antibodies specific for the astrocytic marker GFAP (Chemicon, Paris, France; diluted 1:400 in blocking solution) and TNF-{alpha} (Chemicon; diluted 1:40) were used to detect inflammatory process (49 , 50) . Next, a secondary biotinylated antibody (Amersham, France) was amplified by a streptavidin complex labeled with alkaline phosphatase (Dako, Cambridgeshire, UK). Slices were counterstained in a Mayer’s hematoxylin solution (Sigma, St. Louis, MO, USA) and analyzed by optical microscopy.

TUNEL assay
DNA strand breaks of apoptotic cells were identified in situ by the ApopTag kit (Intergen Compagny, Oxford, UK). Brain cryosections were treated with hydrogen peroxide (0.3%) in PBS for 5 min at room temperature to quench endogenous peroxidase. Slices were rehydrated with the equilibration buffer and incubated with the working strength TdT-based enzymatic solution laced with nucleotides for 1 h in a humidified chamber. The reaction was stopped using the working strength stop/wash buffer. Slices were counterstained with propidium iodide (1 mg/mL) and mounted under a glass coverslip. Pictures were obtained on optical microscope.

Behavioral methods
Apparatus
Open field
A white circular open field (110 cm in diameter and 35 cm height) was illuminated by two indirect 60W bulbs suspended on both side walls. Four different objects were placed into the open field and salient visual and auditory cues were placed in the environment to allow spatial orientation. A camera fixed to the ceiling above the apparatus was connected to a videotrack system (View-point, Lyon, France), allowing the experimenter to record and observe behavior out of the sight of the animals.

Cross maze
As described in ref 51 , the apparatus was made of four arms designing a cross (total size 1 mx78 cm) connecting a central platform (Fig. 1 A). cup containing sucrose pellets was presented at the end of the north arm of the maze. The experimental room contained a few extra-maze cues and was illuminated by two indirect 60W bulbs.



View larger version (8K):
[in this window]
[in a new window]
 
Figure 1. Cross maze apparatus. A) Learning phase. The food goal is presented at the end of the north arm (i.e., goal arm) of the maze. In the south arm, sucrose pellets were present but not available. Animals learn to locate the food goal from pseudo-random departures distributed between east and west arms. B) Orientation test. East, south, and west arms were moved so that the angular relationships they had with the goal arm were modified. The goal arm remained in the same place. To locate the food goal in this modified configuration, animals have to orient themselves using external cues.

Experimental design and testing procedure
Open-field
The rats were daily manipulated for 10 min for 2 wk before surgery and 1 more wk during postoperative recovery. They were subjected to the open field test 28 days after grafting. The general procedure has been described in detail elsewhere (52) . Briefly, rats were subjected to five successive 6 min sessions separated by a 3 min delay during which they were returned to their home cage. During session 1, rats explored an empty environment; for sessions 2–4, their environment contained four objects (A–D). During session 5, the spatial arrangement of the objects was altered to test the reaction-to-spatial change. The location of objects B and D was modified so that D replaced B and B was displaced at the periphery of the arena. To neutralize the possible effects of olfactory cues, the experimenter used plastic gloves when moving and manipulating the objects. The floor was cleaned with water between each session.

Cross maze
This experimental procedure (51) started 38 days after surgery. Animals were food deprived until their weight was adjusted at 85% of normal body weight. All animals had access to water ad libitum. Place learning started once the rats had become acclimated to the maze (i.e., rats consumed food pellets in the maze for a maximum of 2 min). Two rats from macrophage group (one from GFP and one from Nef condition) were discarded because they lacked food motivation.

Each rat received three trials a day. Between each trial rats were returned to a waiting cage by the time another rat ran into the maze. The starting arm was either at the west or east arm and randomly chosen, so that on 2 consecutive days every rat started half of the time by the east arm and half of the time by the west arm. The south arm was neither baited nor a starting point but contained a food cup with unreachable food in order to avoid odor guidance. The time to reach the food goal was recorded. Once the rat began to eat, the timer was stopped and the animal was allowed to consume the food for 10 to 15 s. If a rat failed to reach the goal in 2 min, it was returned to a waiting cage.

After 7 days of learning, all rats reached the criterion (i.e., making no visit to an unbaited arm for 2 consecutive days; 6 trials). After a rat reached the criterion, it was submitted to an orientation test consisting of reaching the goal from modified starting points. In the modified configuration, the position of the goal arm and distal environmental cues remained unchanged (Fig. 1B ).

Data collection and analysis
Open-field
The video track software collected automatically locomotor activity in terms of distance and exploratory activity in terms of time of entry in areas containing objects.

Locomotor activity was compared between groups using a t test during the first session before introduction of objects.

Times spent in areas containing each object were averaged across individuals per group. A repeated measure ANOVA for paired comparison (Statview program) was carried out. The main factors were "G" as the between-subject measure and "session" as the within-subject measure. To ascertain whether rats showed habituation, we compared sessions 2, 3, and 4.

Reaction-to-spatial-change was compared between groups using a t test performed on the difference between the time spent investigating the exchanged objects and the nonexchanged ones: session 5 minus session 4.

Cross maze
In this task, the variable was the time to reach the goal. We carried out repeated measures of variance to ascertain the effects of the main factors and t tests for post hoc analysis.

During learning, session was the within-subject factor and group the between-subject factor.

In the orientation test, group was the between-subject factor and "condition" was the within-subject factor with two levels, standard configuration vs. test.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Highly efficient gene transfer into primary cultures of bone marrow-derived macrophages
Nondividing terminally differentiated BMDM were transduced with TRIP vector deleted in the U3 region of the LTR and expressing the HIV-1 nef gene under the control of the CMV internal promoter. Fifteen days after transduction, FACS analysis was performed to assess gene transfer in the BMDM (Fig. 2 A). We observed a signal showing that >70% of macrophages expressed Nef (M2) compared with untransduced BMDM (M1) (Fig. 2B ). This highly efficient transduction was obtained using a concentration of TRIP-Nef vector particles corresponding to 300 ng of p24 (see Materials and Methods). A control of transduction was assessed using GFP lentiviral particles at a concentration of 150 ng of p24. As shown in Fig. 2C , >75% of BMDM was efficiently transduced with TRIP-GFP vector (M2) compared with untransduced cells (M1). The sustained Nef expression remains stable for at least 1 month in vitro without any cytotoxic effect noted in the BMDM culture (data not shown).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 2. TRIP-Nef efficient transduction of BMDM. A) Stable cell size and granularity dot plot showing the selected region corresponding to the BMDM cell population analyzed by FACS. These parameters were identical all through the experiment for every conditions (untransduced cells, TRIP-Nef BMDM, TRIP-GFP BMDM). B) The pick signal (M2) shows that 70% of the macrophages expressed Nef. C) Control measures were assessed by TRIP-GFP transduction (M2). Both transductions were compared with untransduced cells (M1).

Characterization of transduced cells
Primary culture of BMDM (Fig. 3 A) was characterized by immunohistochemical procedure using Nef antibody or autofluorescence detection for GFP. As shown in Fig. 3B , after 15 days of transduction the greatest part of BMDM expressed Nef. The same result was obtained using TRIP-GFP vector as a control of transduction (Fig. 3C ). All BMDM came from the mononuclear phagocyte lineage as shown using ED1 and Mac-1 antibodies (41) .



View larger version (60K):
[in this window]
[in a new window]
 
Figure 3. Characterization of transduced BMDM. A) Typical shape of primary macrophages in culture. B) BMDM transduced with TRIP-Nef vector and labeled with a specific antibody. C) GFP BMDM observed by autofluorescence. D) Detection of Nef by Western blot; GFP BMDM extracts (line a), Nef BMDM extracts (line b), Nef BMDM cell culture supernatant (line c).

Western blot analysis was performed under nondenaturating conditions on cellular extracts and supernatants of BMDM transduced with the lentiviral TRIP vector expressing Nef or GFP. In the cellular extracts of Nef-transduced BMDM (Fig. 3D , line b), Nef can be detected using a monoclonal antibody as a 27 kDa protein. The same antibody was unable to reveal Nef expression in the concentrated supernatant of Nef-transduced BMDM (Fig. 3D , line c). No signal was observed in the cellular extract of GFP-transduced BMDM (Fig. 3D , line a).

Viability of transduced macrophages transplanted into the rat hippocampus
The high efficiency of Nef primary macrophages transduction allowed us to investigate the effect of Nef in the rat brain, so we performed engraftments of Nef-transduced BMDM into the hippocampus area (Fig. 4 A).



View larger version (52K):
[in this window]
[in a new window]
 
Figure 4. Intracerebral Injections. A) Schematic illustration of anatomical localization of the injections performed in the hippocampus. Histological results of Nef (B, D) and GFP (C, E) 2 months after cell or particle grafts.

We observed that Nef was detected around the injection site of transplanted Nef-BMDM 2 months after the graft (Fig. 4B ). Similar results were obtained with GFP-transduced BMDM (Fig. 4C ). Analysis of direct vector particles injection showed that Nef or GFP particles surrounded the needle track in the hippocampus (Fig. 4D, E , respectively).

Chemotactic and neurotoxic effects of transplanted Nef-BMDM in the rat hippocampus
Two months after the graft, transduced Nef and GFP BMDM were still alive at the injection site and could be detected using Mac-1 antibody (Fig. 5 A). The presence of Mac-1-positive cells around the injection site of Nef-transduced-BMDM (Fig. 5A , bottom) suggests the recruitment of peripheral or resident monocytes/ macrophages as a consequence of Nef expression. Similar results were observed around the injection sites of Nef viral particles (data not shown). By contrast, in the brain of rats grafted with GFP-transduced BMDM, only grafted macrophages were stained with Mac-1 antibody (Fig. 5A , top).



View larger version (76K):
[in this window]
[in a new window]
 
Figure 5. Histological analyses of Nef expression in the rat hippocampus. Comparative analysis of Nef (bottom) and GFP (top) BMDM graft. A) Detection of monocytes/macrophages by Mac-1 in and around the transplant. B) Detection of local astrogliosis around the Nef BMDM graft using GFAP marker compared with GFP BMDM. C) Expression of TNF-{alpha} around the astrogliosis in Nef graft. D) Absence of apoptosis events in both graft conditions. Black bars indicate the few apoptotic cells found in the slice.

We examined each transplanted and injected brain slice for astrocytes reactivity to assess local astrogliosis using GFAP astrocytic marker. Two months after the graft, enhanced GFAP staining was detected around the Nef-transduced BMDM (Fig. 5B , bottom) whereas no significant sign of astrogliosis was seen around the graft of GFP positive BMDM (Fig. 5B , top).

As brain damage can be induced by direct or indirect mechanisms involving proinflammatory cytokines, we examined the presence of TNF-{alpha} expression in the rat brain. We observed about the Nef-transduced BMDM a significant signal of TNF-{alpha} 2 months after the engraftment (Fig. 5C , bottom). Moreover, TNF-{alpha} expression was detected around the astrogliosis only in the case of Nef-BMDM graft. No significant astrogliosis or TNF-{alpha} expression was detected around the GFP-BMDM graft (Fig. 5C , top).

The next step was to analyze whether Nef could induce an apoptotic effect in the rat brain as a consequence of the inflammatory process. Figure 5D illustrates that no apoptosis corpus was observed 2 months after Nef-BMDM or GFP-BMDM transplantation into the rat hippocampus.

Behavioral results
Exploratory activity
Statistical ANOVA for exploratory activity is summarized in Table 1 . It shows no statistical difference between groups (macrophages GFP vs. macrophages Nef and particles GFP vs. particles Nef) for locomotor activity and habituation, although there is a tendency for animals receiving macrophages expressing Nef to exhibit a higher level of exploratory activity toward the objects (illustrated in Fig. 6 ). We cannot exclude this lack of statistical difference between groups as an expression of a high variability between Nef individuals. There is no significant interaction group X session, indicating a similar habituation in both groups.


View this table:
[in this window]
[in a new window]
 
Table 1. Statistical analyses for exploratory activitya



View larger version (21K):
[in this window]
[in a new window]
 
Figure 6. Exploratory behavior toward objects. A) Locomotor activity and habituation. The top graph shows the locomotor activity exhibited in the empty open field (session 1) by macrophage and particle rats. No difference was observed between GFP (white) and Nef (black) groups. The bottom graphs show habituation of exploratory activity toward the objects during sessions 2–4. For particle (left) and macrophage (right) groups, GFP (open circle) and Nef (black square) rats exhibited similar time of contact with objects over sessions. B) Reaction to spatial change for particle (left) and macrophage (right) groups, GFP animals displayed a higher level of exploration for session 5 than for session 4, exhibiting a normal reaction to spatial change. The reaction to spatial change is not observed for Nef animals.

However, the reaction-to-spatial-change is significantly different for the GFP and Nef animals of the particle group (time of object exploration for S5-S4, t=0.04), and nearly reach significance for the GFP and Nef animals of the macrophage group (time of object exploration for S5-S4, t=0.054).

Place learning
Statistical analyses of variance for place learning and orientation test are summarized in Table 2 .


View this table:
[in this window]
[in a new window]
 
Table 2. Main statistical effects for place learning and orientation testa

Statistical analyses conducted on "time to reach the goal" showed a main effect of session, no group effect and no significant group X session interaction, indicating that all animals learned the task in 7 days or less and did not differ in the time needed to reach the goal as illustrated in Fig. 7 A, B.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 7. Spatial learning of food location and orientation test. Top graphs show learning curves for particle (A) and macrophage (B) groups over daily sessions. GFP (open circle) and Nef (black square) rats learn the task to a similar extent. Bottom graphs show the time to reach the goal during the orientation test. Nef animals (particle, C; macrophage, D) increased significantly the time to reach the goal in the modified configuration (test) compared with the standard configuration (learning). This change in behavior is not observed for GFP animals.

Orientation challenge
We compared the time to reach the goal for GFP and Nef animals (group effect) before modification of the spatial arrangement of the maze arms (performance at the 7th day of training) and during the orientation test for which configuration of the apparatus is modified (condition effect). Statistical results of the repeated measures of variance for the main effects are given in Table 2 . As illustrated in Fig. 7C, D , these results suggest that the orientation test did not affect the performance of both groups in the same way.

In the macrophage group, post hoc analysis revealed a significant condition effect for group 2 (Nef) (t=2.8, ddl=4, P=0.048) but not for group 1 (GFP) (t<1, NS). The time to find the goal for the Nef group was longer during the orientation test than during the learning condition, but remained stable for the GFP animals whatever the configuration of the maze.

In the particle groups, post hoc analysis showed a condition effect for group 2 (Nef) (t=3.24, ddl=4, P=0.03) but not for group 1 (GFP) (t<1, NS).

Overall, these results show that only Nef animals (macrophage and particle) spent significantly more time reaching the goal in the modified configuration than in the standard configuration, suggesting that the ability to adapt their behavior to sudden configural changes is altered in Nef animals compared with GFP animals.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
In this report we provide the first evidence that the graft of Nef-transduced BMDM into the rat brain can induce an early observable neuropathology (i.e., inflammatory effects associated with cognitive defects.

Our in vitro results demonstrate that HIV-1 lentiviral vector allowed high and stable expression of Nef in transduced macrophages and correct maturation and expression of Nef in the BMDM. Moreover, neither cytotoxic effects nor secretion of Nef protein from the cell was observed in the culture over 1 month after transduction. This suggests that our in vivo observations are unlikely to result from the effect of the secreted protein but rather from the expression of Nef by the macrophages.

In vivo, we grafted BMDM expressing Nef into the hippocampus area to 1) detect HIV-1-gene sequences (in particular, gag and nef) into the hippocampus (53) , and behavioral effects of hippocampal damage in the rat are described in the literature (see ref 54 for review) and because 2) earlier studies have described the central role of Nef in toxic mechanisms, notably by modulating the intracellular machinery of the host cell (55 56 57) . It has been shown in vivo that HIV neuropathology may be correlated with the presence of Nef expressed in astrocytes (26 , 27 , 53) . 3) We developed an efficient transduction method for targeting original HIV cells (macrophages) using a TRIP vector (41) .

To mimic the human HIV neuropathology in an animal model, we grafted onto the rat hippocampus macrophages ex vivo transduced with TRIP-Nef vector.

One month after grafting, we began the investigation of behavioral functions in transplanted animals by first conducting open field exploratory behavior. Our results showed that reaction to spatial change is affected in animals receiving Nef. Indeed, we did not observe increased locomotor activity or impaired habituation of exploratory activity as would be expected if the hippocampus was lesioned (58 , 59) . However, the reaction to spatial change is impaired in Nef animals, suggesting that spatial memory is affected in these rats. The ability to memorize a spatial configuration is known to rely on hippocampal function in animals (60 61 62) and humans (63 , 64) . Although supporting spatial representation is a main characteristic of the hippocampus (65) , two primary reasons, not mutually exclusive, can explain this incomplete effect.

First, the construction of spatial representation is one of the major functions in rodents. Thus, it is supported by the functioning of several interconnected brain areas including the prefrontal and parietal cortices, the septum, CA1 and CA3 hippocampus, and the amygdala (54 ,61 ). Such a redundant function is unlikely to be affected by a minor lesion of one of the targeted area, as may have been the case only 1 month after grafting. Our histological results indicated only focal inflammation of the hippocampus around the graft (Fig. 5A ) whereas earlier work showed that complete lesion or inactivation of the hippocampus is necessary to induce robust impairment in place representation (58) . Moreover, the Nef transgenic mouse model described by Hanna and colleagues (30) supports the view that a certain level of expression of the transgene is necessary to achieve sufficient protein synthesis to induce an AIDS-like pathogenicity (30) .

Second, the open field test might have been carried out too early for the hippocampus to be fully affected by Nef expression. This explanation is supported by the observation that the performance is quite variable among rats receiving Nef. This variability may be due to individual factors in Nef action within the hippocampus over time. This hypothesis is supported by the drastic behavioral impairments observed in the spatial learning task.

In the spatial learning experiment, animals receiving particles or macrophages expressing Nef showed normal spatial learning of the food goal location. Animals receiving the control protein GFP and those receiving Nef demonstrated significant decreases in the time needed to reach the food, suggesting that all animals learn to locate the goal progressively. However, several studies have shown that rats can locate spatial goals by computing intra- and extra-maze cues and that the hippocampus participates crucially in the integration of distal configural cues (51 , 62 , 66) .

It is known that spatial tasks favor in rodents the development of strategies that affect learning processes (67 68 69 70) . Animals spontaneously display place strategies that were reinforced in our protocol (51) . During the orientation test, the angular relationships between the arms of the maze were altered such that the arm containing the food goal was the only place having stable spatial relationships with the external environment. Our results for this test showed that GFP rats still performed as efficiently as in the standard configuration, suggesting they were able to use a memorized configuration of the goal based on distal landmarks. On the contrary, Nef animals (for either the macrophage or particle groups) showed a marked impairment, as for these groups the time needed to reach the goal significantly increased after alteration of angular relationships between the arms of the maze. We previously showed that in this configuration, normal animals solve the task using primarily extra-maze cues, leaving intra-maze cues irrelevant (51) . The ability to adapt the behavior to sudden configural changes based on spatial strategy implies using and updating the spatial relationships between the components of the environment. These cognitive abilities, known to rely on the integrity of the hippocampal (58 , 59 , 61) , are specifically altered in Nef animals. We can therefore infer that animals receiving Nef exhibit cognitive defects resulting from hippocampal dysfunction.

At the completion of behavioral experiments, animals were killed and the brains were removed for histopathological analyses. Our results showed that 2 months after transplantation, the presence of Nef in the rat hippocampus induced a significant astrogliosis and a recruitment of monocytes/macrophages around the injection site of the graft. These histopathological effects are unlikely to be due to a general effect of a foreign protein expressed in the brain, as GFP-BMDM did not produce a similar astrogliosis. Our results are in accordance with those of Koedel and colleagues (40) , who demonstrated that injection of soluble HIV-1 Nef in the brain induced the recruitment of leukocytes toward the inflamed region. However, as they injected a soluble form of the protein, they conclude that Nef represents the viral factor involved in HIV neuropathology. Our present data further show that not only is the protein itself able to induce a neuropathology but that, as in infected patients, the protein expressed by the HIV target cells (i.e., macrophages) induced an early noticeable neurotoxicity. Indeed, it has never been shown that Nef is secreted at a sufficient rate to be able to induce an inflammatory process. Therefore, we hypothesize that Nef modifies the cellular machinery of the HIV target cells, which secondarily spreads inflammatory processes toward the surrounding cells of the target area. In accordance with this hypothesis, we show a significant expression of the proinflammatory cytokine TNF-{alpha} specifically around the injection site of the Nef grafts, an inflammatory process not observed in GFP-transduced cells. The TNF-{alpha} secretion seems to be corroborated with the localization of astrogliosis, but could be the consequence of the expression of Nef by the macrophages. In fact, Nef neurotoxicity has been linked to the production of quinolinic acid by macrophages. The quinolinic acid, as the proinflammatory cytokine TNF-{alpha}, has been shown to be produced by activated macrophages in several inflammatory brain diseases, including AIDS dementia complex (37 , 71 72 73) .

In the literature, HIV-1 neurotoxic proteins (i.e., gp120 and tat) have been shown to induce apoptotic events (74 75 76) . It has been further suggested that apoptosis is mediated through indirect mechanisms involving modifications of the signaling pathway of infected cells (77 78 79 80 81) . However, the results concerning Nef are controversial. Rasola and collaborators (82) concluded that Nef enhances programmed cell death, whereas other studies have described the role of Nef in promoting resting cell infection (83) or argued that Nef is associated with anti-apoptotic signals (84 , 85) . In our study, we did not find any apoptotic events associated with astrogliosis or TNF-{alpha} expression.

To conclude, our results showed that Nef, through its expression by HIV target cells, is one of the viral factors that influence the early development of a neuropathology that can produce cognitive impairments. Moreover, in accordance with the results obtained in other laboratories (40 , 86) , our data suggest that Nef may mediate chemotaxic effects and a reactive response by macrophages and astrocytes. Our study has investigated, for the first time, both behavioral and histopathological effects of a viral HIV-1 protein expressed by the natural HIV-1 target cells grafted onto a specific brain area known to be affected in HIV-demented patients. The rat model of HIV-associated neuropathology should be useful for the study of fundamental mechanisms of neurotoxicity exerted by a specific protein expressed by macrophages within the brain. Furthermore, it emphasizes the interest of correlating histopathological and behavioral data in evolutive neuropathologies affecting cognitive functions.


   ACKNOWLEDGMENTS
 
E.M. was supported by a fellowship from the Pasteur-Weizmann Fundation. S.G. was supported by a postdoctoral grant from "la Fondation pour la Recherche Médicale" (SIDAction). This work was also performed by grants from Agence Nationale pour la Recherche contre le SIDA and l’Institut Pasteur. We would like to acknowledge Pr. Sylvie van der Werf for critical reading of the manuscript, Brian Molles for correcting the English and two anonymous referees for helpful comments.

Received for publication June 24, 2004. Accepted for publication July 26, 2004.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. De Gans, J., Portegies, P. (1989) Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin. Neurol. Neurosurg. 91,199-219[CrossRef][Medline]
  2. Gendelman, H. E., Persidsky, Y., Ghorpade, A., Limoges, J., Stins, M., Fiala, M., Morrisett, R. (1997) The neuropathogenesis of the AIDS dementia complex. AIDS 11(Suppl. A),S35-S45
  3. Gray, F. (1998) Dementia and human immunodeficiency virus infection. Rev. Neurol. 154(Suppl. 2),S91-S98
  4. Tardieu, M. (1999) HIV-1-related central nervous system diseases. Curr. Opin. Neurol. 12,377-381[CrossRef][Medline]
  5. Suarez, S., Baril, L., Stankoff, B., Khellaf, M., Dubois, B., Lubetzki, C., Bricaire, F., Hauw, J.-J. (2001) Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS 15,195-200[CrossRef][Medline]
  6. Nath, A., Berger, J. (2004) HIV dementia. Curr. Treat. Options Neurol. 6,139-151[Medline]
  7. Navia, B. A. (1997) Clinical and biologic features of the AIDS dementia complex. Neuroimaging Clin. N. Am. 7,581-592[Medline]
  8. Everall, I. P., Luthert, P. J., Lantos, P. L. (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337,1119-1121[CrossRef][Medline]
  9. Berger, J. R., Arendt, G. (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems. J. Psychopharmacol. 14,214-221[Abstract]
  10. Suarez, S., Granon, S. (2000) Role du VIH dans les troubles cognitifs modérés. Moulignier, A. Mrejen, S. eds. Flammarion-Médecine/Sciences, France ,40-51 "Neuro-sida: complications neurologiques liees au VIH,"
  11. Kure, K., Lyman, W. D., Weidenheim, K. M., Dickson, D. W. (1990) Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am. J. Pathol. 136,1085-1092[Abstract]
  12. Epstein, L. G., Gendelman, H. E. (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33,429-436[CrossRef][Medline]
  13. Takahashi, K., Wesselingh, S. L., Griffin, D. E., McArthur, J. C., Johnson, R. T., Glass, J. D. (1996) Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39,705-711[CrossRef][Medline]
  14. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., Oldstone, M. B. (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83,7089-7093[Abstract/Free Full Text]
  15. Tornatore, C., Nath, A., Amemiya, K., Major, E. O. (1991) Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65,6094-6100[Abstract/Free Full Text]
  16. Bagasra, O., Lavi, E., Bobroski, L., Khalili, K., Pestaner, J. P., Tawadros, R., Pomerantz, R. J. (1996) Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10,573-585[Medline]
  17. Messam, C. A., Major, E. O. (2000) Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J. Neurovirol. 6(Suppl. 1),S90-S94
  18. Glass, J. D., Wesselingh, S. L. (2001) Microglia in HIV-associated neurological diseases. Microsc. Res. Tech. 54,95-105[CrossRef][Medline]
  19. Nottet, H. S., Flanagan, E. M., Flanagan, C. R., Gelbard, H. A., Gendelman, H. E., Reinhard, J. F., Jr (1996) The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes. J. Neurovirol. 2,111-117[Medline]
  20. Persidsky, Y., Buttini, M., Limoges, J., Bock, P., Gendelman, H. E. (1997) An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J. Neurovirol. 3,401-416[Medline]
  21. Kelder, W., McArthur, J. C., Nance-Sproson, T., McClernon, D., Griffin, D. E. (1998) Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 44,831-835[CrossRef][Medline]
  22. Kaul, M., Lipton, S. A. (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96,8212-8216[Abstract/Free Full Text]
  23. Rostasy, K., Monti, L., Yiannoutsos, C., Kneissl, M., Bell, J., Kemper, T. L., Hedreen, J. C., Navia, B. A. (1999) Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. Ann. Neurol. 46,207-216[CrossRef][Medline]
  24. Ranki, A., Lagerstedt, A., Ovod, V., Aavik, E., Krohn, K. J. (1994) Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 139,365-378[CrossRef][Medline]
  25. Ranki, A., Nyberg, M., Ovod, V., Haltia, M., Elovaara, I., Raininko, R., Haapasalo, H., Krohn, K. (1995) Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9,1001-1008[Medline]
  26. Tornatore, C., Chandra, R., Berger, J. R., Major, E. O. (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44,481-487
  27. Saito, Y., Sharer, L. R., Epstein, L. G., Michaels, J., Mintz, M., Louder, M., Golding, K., Cvetkovich, T. A., Blumberg, B. M. (1994) Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44,474-481
  28. Kestler, H. W., III, Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., Desrosiers, R. C. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65,651-662[CrossRef][Medline]
  29. Skowronski, J., Parks, D., Mariani, R. (1993) Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12,703-713[Medline]
  30. Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S., Jolicoeur, P. (1998) Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95,163-175[CrossRef][Medline]
  31. Sporer, B., Koedel, U., Paul, R., Kohleisen, B., Erfle, V., Fontana, A., Pfister, H. W. (2000) Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J. Neuroimmunol. 102,125-130[CrossRef][Medline]
  32. Kramer-Hammerle, S., Kohleisen, B., Hohenadl, C., Shumay, E., Becker, I., Erfle, V., Schmidt, J. (2001) HIV type 1 Nef promotes neoplastic transformation of immortalized neural cells. AIDS Res. Hum. Retroviruses 17,597-602[CrossRef][Medline]
  33. Liu, X., Schrager, J. A., Lange, G. D., Marsh, J. W. (2001) HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations. J. Biol. Chem. 276,32763-32770[Abstract/Free Full Text]
  34. Percario, Z., Olivetta, E., Fiorucci, G., Mangino, G., Peretti, S., Romeo, G., Affabris, E., Federico, M. (2003) Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery. J. Leukoc. Biol. 74,821-832[Abstract/Free Full Text]
  35. Glass, J. D., Johnson, R. T. (1996) Human immunodeficiency virus and the brain. Annu. Rev. Neurosci. 19,1-26[CrossRef][Medline]
  36. Gallo, P., Frei, K., Rordorf, C., Lazdins, J., Tavolato, B., Fontana, A. (1989) Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23,109-116[CrossRef][Medline]
  37. Achim, C. L., Heyes, M. P., Wiley, C. A. (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J. Clin. Invest. 91,2769-2775
  38. Sasseville, V. G., Smith, M. M., Mackay, C. R., Pauley, D. R., Mansfield, K. G., Ringler, D. J., Lackner, A. A. (1996) Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 149,1459-1467[Abstract]
  39. Schmidtmayerova, H., Sherry, B., Bukrinsky, M. (1996) Chemokines and HIV replication. Nature (London) 382,767[CrossRef][Medline]
  40. Koedel, U., Kohleisen, B., Sporer, B., Lahrtz, F., Ovod, V., Fontana, A., Erfle, V., Pfister, H. W. (1999) HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J. Immunol. 163,1237-1245[Abstract/Free Full Text]
  41. Mordelet, E., Kissa, K., Calvo, C. F., Lebastard, M., Milon, G., van der Werf, S., Vidal, C., Charneau, P. (2002) Brain engraftment of autologous macrophages transduced with a lentiviral flap vector: an approach to complement brain dysfunctions. Gene Ther. 9,46-52[CrossRef][Medline]
  42. Tushinski, R. J., Oliver, I. T., Guilbert, L. J., Tynan, P. W., Warner, J. R., Stanley, E. R. (1982) Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28,71-81[CrossRef][Medline]
  43. Stanley, E. R., Heard, P. M. (1977) Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J. Biol. Chem. 252,4305-4312[Free Full Text]
  44. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272,263-267[Abstract]
  45. Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., Charneau, P. (2000) HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101,173-185[CrossRef][Medline]
  46. Sirven, A., Pflumio, F., Zennou, V., Titeux, M., Vainchenker, W., Coulombel, L., Dubart-Kupperschmitt, A., Charneau, P. (2000) The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96,4103-4110[Abstract/Free Full Text]
  47. Barclay, A. N. (1981) Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens. Immunology 44,727-736[Medline]
  48. Dijkstra, C. D., Dopp, E. A., Joling, P., Kraal, G. (1985) The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54,589-599[Medline]
  49. Balasingam, V., Yong, V. W. (1996) Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 16,2945-2955[Abstract/Free Full Text]
  50. Spatafora, M., Merendino, A., Gjomarkaj, M., Chiappara, G., Melis, M., Bellia, V., Bonsignore, G. (1988) Tumor necrosis factor release by pulmonary alveolar macrophages. Respiration 54(Suppl. 1),73-77
  51. Cressant, A., Granon, S. (2003) Definition of a new maze paradigm for the study of spatial behavior in rats. Br. Res. Protocol 12,116-124
  52. Granon, S., Save, E., Buhot, M. C., Poucet, B. (1996) Effortful information processing in a spontaneous spatial situation by rats with medial prefrontal lesions. Behav. Br. Res. 78,147-154[CrossRef][Medline]
  53. Torres-Munoz, J., Stockton, P., Tacoronte, N., Roberts, B., Maronpot, R. R., Petito, C. K. (2001) Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J. Neuropathol. Exp. Neurol. 60,885-892[Medline]
  54. Thinus-Blanc, C. (1996) Animal Spatial Cognition: Behavioural and Brain Approach World Scientific Publishing Co. Pte. Ltd. Singapore.
  55. Ambrosini, E., Slepko, N., Kohleisen, B., Shumay, E., Erfle, V., Aloisi, F., Levi, G. (1999) HIV-1 Nef alters the expression of betaII and epsilon isoforms of protein kinase C and the activation of the long terminal repeat promoter in human astrocytoma cells. Glia 27,143-151[CrossRef][Medline]
  56. Kohleisen, B., Shumay, E., Sutter, G., Foerster, R., Brack-Werner, R., Nuesse, M., Erfle, V. (1999) Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes. AIDS 13,2331-2341[CrossRef][Medline]
  57. Robichaud, G. A., Poulin, L. (2000) HIV type 1 nef gene inhibits tumor necrosis factor alpha-induced apoptosis and promotes cell proliferation through the action of MAPK and JNK in human glial cells. AIDS Res. Hum. Retroviruses 16,1959-1965[CrossRef][Medline]
  58. Save, E., Poucet, B., Foreman, N., Buhot, M.-C. (1992) Object exploration and reaction to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation. Behav. Neurosci. 106,447-456[CrossRef][Medline]
  59. Buhot, M.-C., Patra, S. K., Naili, S. (1995) Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Eur. J. Pharmacol. 285,221-228[CrossRef][Medline]
  60. Morris, R. G. M., Garrud, P., Rawlins, J. N. P., O’Keefe, J. (1982) Place navigation impaired in rats with hippocampal lesions. Nature (London) 297,681-683[CrossRef][Medline]
  61. Compton, D. M., Griffith, H. R., McDaniel, W. F., Foster, R. A., Davis, B. K. (1997) The flexible use of multiple cue relationships in spatial navigation: a comparison of water maze performance following hippocampal, medial septal, prefrontal cortex, or posterior parietal cortex lesions. Neurobiol. Learn. Mem. 68,117-132[CrossRef][Medline]
  62. Cressant, A., Muller, R. U., Poucet, B. (1997) Failure of centrally placed objects to control the firing fields of hippocampal place cells. J. Neurosci. 17,2531-2542[Abstract/Free Full Text]
  63. Berthoz, A. (1997) Parietal and hippocampal contribution to topokinetic and topographic memory. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352,1437-1448[CrossRef][Medline]
  64. Duzel, E., Habib, R., Rotte, M., Guderian, S., Tulving, E., Heinze, H. J. (2003) Human hippocampal and parahippocampal activity during visual associative recognition memory for spatial and nonspatial stimulus configurations. J. Neurosci. 23,9439-9444[Abstract/Free Full Text]
  65. Poucet, B., Benhamou, S. (1997) The neuropsychology of spatial cognition in the rat. Crit. Rev. Neurobiol. 11,101-120[Medline]
  66. Sutherland, R. J., Kolb, B., Whishaw, I. Q., Becker, J. B. (1982) Cortical noradrenaline depletion eliminates sparing of spatial learning after neonatal frontal cortex damage in the rat. Neurosci. Lett. 32,125-130[CrossRef][Medline]
  67. Becker, J. T., Olton, D. S. (1981) Cognitive mapping and hippocampal system function. Neuropsychologia 19,733-744[CrossRef][Medline]
  68. Granon, S., Vidal, C., Thinus-Blanc, C., Changeux, J.-P., Poucet, B. (1994) Working memory, response selection, and effortful processing in rats with medial prefrontal lesions. Behav. Neurosci. 108,883-891[CrossRef][Medline]
  69. Schenk, F., Grobéty, M. C., Lavenex, P., Lipp, H. P. (1995) Dissociation between basic components of spatial memory in rats. Alleva, E.et al eds. Behavioural Brain Research in Naturalistic and Semi-Naturalistic Settings ,277-300 Kluwer Academic Press
  70. Hodges, H. (1996) Maze procedures: the radial-arm and water maze compared. Cognit. Br. Res. 3,167-181
  71. Smith, D. G., Guillemin, G. J., Pemberton, L., Kerr, S., Nath, A., Smythe, G. A., Brew, B. J. (2001) Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J. Neurovirol. 7,56-60[CrossRef][Medline]
  72. Kedzierska, K., Crowe, S. M. (2001) Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12,133-150[Medline]
  73. Varfolomeev, E. E., Ashkenazi, A. (2004) Tumor necrosis factor; an apoptosis JuNKie?. Cell 116,491-497[CrossRef][Medline]
  74. Banda, N. K., Tomczak, J. A., Shpall, E. J., Sipple, J., Akkina, R. K., Steimer, K. S., Hami, L., Curiel, T. J., Singer Harrison, G. (1997) HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells. Apoptosis 2,61-68[CrossRef][Medline]
  75. Corasaniti, M. T., Nistico, R., Costa, A., Rotiroti, D., Bagetta, G. (2001) The HIV-1 envelope protein, gp120, causes neuronal apoptosis in the neocortex of the adult rat: a useful experimental model to study neuroaids. Funct. Neurol. 16,31-38[Medline]
  76. Haughey, N. J., Mattson, M. P. (2002) Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J. Acquir. Immune Defic. Syndr. 31,S55-S61
  77. Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E., Geiger, J. D. (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protecti